首页 | 本学科首页   官方微博 | 高级检索  
     检索      

中心性浆液性脉络膜视网膜病变治疗新进展
引用本文:于海娟,张天资.中心性浆液性脉络膜视网膜病变治疗新进展[J].内蒙古民族大学学报(自然科学版),2014(4):470-473.
作者姓名:于海娟  张天资
作者单位:1. 内蒙古民族大学 蒙医药学院,内蒙古 通辽 028000; 奈曼旗人民医院,内蒙古 大沁他拉 028300
2. 内蒙古民族大学 附属医院,内蒙古 通辽,028000
摘    要:中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy,CSC)是一种常见的视网膜病,其病因不明,是一种自限性疾病,但病情迁延不愈,会导致患者视功能的损害.随着人们对本病的认识不断发展,更多眼科医生主张积极地治疗,笔者就CSC的治疗进展进行阐述.

关 键 词:中心性浆液性脉络膜视网膜病变  治疗  进展

New Progress in Treatment of Central Serous Chorioretinopathy
YU Hai-juan,ZHANG Tian-zi.New Progress in Treatment of Central Serous Chorioretinopathy[J].Journal of Inner Mongolia University for the Nationalities(Natural Sciences),2014(4):470-473.
Authors:YU Hai-juan  ZHANG Tian-zi
Institution:YU Hai-juan, ZHANG Tian-zi ( 1.Postgraduate of 2011, College of Mongolian Medicine and Pharmacy, Inner Mongolia University for Nationalities, Tongliao 028000, China; 2.The People's Hospital of Naiman Banner, Daqintala 028300, China; 3.Affiliated Hospital, Inner Mongolia University for Nationalities, Tongliao 028000, China)
Abstract:Central serous chorioretinopathy(CSC) is a common retinopathy, which is a self-limited disease. The reason is unknown. If the disease deferment, the patients' visual function can be affected. With the development of understanding of the disease, more ophthalmologists advocate actively treatment. This article will shed light on the treatment of CSC.
Keywords:Central serous chorioretinopathy  Therapy  Progress
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号